4:00 pm 03/14/25 nyse | $usd | post-market: $162.50 -0.31 ( -0.19% ) 7:50 pm analyze with ai summary ratings financials earnings dividends valuation growth profitability momentum peers options charting all all analysis analysis comments comments news news transcripts & insights transcripts & ...
JNJ ▲2.31% Johnson & Johnson 46 6 NEW NYSE:JNJ (USA)Ordinary Shares $ 157.47+3.56 (+2.31%)07:08 PM EST P/E: 17.52 P/B: 5.30 Market Cap: $ 379.48B Enterprise V: $ 383.01B Volume: 10.97M Avg Vol (2M): 10.57M Warning! GuruFocus detected 4 Medium warning signs with JNJ.Try a...
though we acknowledge the market has moved up as well. still, the company has grown earnings in that time, justifying the increased share price. what is more, from a technical perspective, we note that on every major pullback (
Day’s Range$0 - $0 52-Week Range$143.13 - $168.85 Previous Close$149.31 Volume8.39M Average Volume (3M)6.63M Market Cap $359.99B Enterprise Value$375.44B Total Cash (Recent Filing)$20.30B Total Debt (Recent Filing)$35.75B Price to Earnings (P/E)24.7 ...
Johnson & Johnson Price Performance Shares of NYSE JNJ opened at $165.61 on Monday. Johnson & Johnson has a fifty-two week low of $150.11 and a fifty-two week high of $186.69. The stock has a market cap of $431.30 billion, a price-to-earnings ratio of 24.57, a PEG ratio of...
After recovering some of its share price losses from December 2018, Johnson & Johnson (NYSE:JNJ) offers potential for strong asset appreciation. Advertisement. While Johnson & Johnson experienced share price volatility like other equities, the JNJ stock has been a good safe haven for i...
Typically, when actual earnings out-perform the analysts' estimate, a stock's share price tends to rise; when the actual earnings come in under the analysts' estimate, the stock's share price tends to fall. Detailed Earnings Estimates The second table on the Estimates page shows analyst ...
Johnson & Johnson(NYSE:JNJ) shareholders are waking up with a shrug today. JNJ stock is slightly off after the thinnest of earnings beats, with the save coming from the company’s pharmaceutical business. For the quarter ended in September, JNJ earned $4.68 billion, or $1.68 per share, on...
Johnson & Johnson(NYSE: JNJ) Q4 2024 Earnings Call Jan 22, 2025,8:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good morning and welcome to Johnson & Johnson's fourth quarter 2024earnings conference callAll participants will be in a ...
Johnson & Johnson (NYSE: JNJ) Q3 2023 Earnings Call datedOct. 17, 2023 Corporate Participants: Jessica Moore—Vice President – Investor Relations Joseph J. Wolk—Executive Vice President, Chief Financial Officer Joaquin Duato—Chairman and Chief Executive Officer ...